NPCE
Neuropace, Inc.Healthcare$14.65
◆ Neutral
Mkt Cap: $493.2M|Float: 22.9M|SI: 4.1%|DTC: 4.2
Data as of market close Apr 2, 2026
IV Rank
11
IV Pctl
11%
HV 20d
53.8%
52W Range
$8-$19
ATR(14)
$0.65
Exp. Move
±11.1%
P/C Ratio
1.93
Earnings
May 12
GEX Positive
DEX Long
Net Call Premium
IV Low
Max Pain Below
Exp. Move Wide
High Put/Call
NPCE Key Options Data
- IV Rank
- 11.4%
- Total GEX
- $0.00B
- Total DEX
- $0.0M
- Max Pain
- $10.00
- Expected Move
- ±11.1%
- Put/Call OI
- 1.93
- Net Premium
- $0.0M
- Spot Price
- $14.65
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-05-15 | 43 | ±$1.62 | ±11.1% | $13.02 | $16.27 |
| 2026-08-21 | 141 | ±$2.80 | ±19.1% | $11.85 | $17.45 |
Explore NPCE options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.